Clinical Trial Update: Symptomatic Remission and Social Function in Participants Treated With Paliperidone Extended Release (ER) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating paliperidone extended-release for achieving symptomatic remission and improving social functioning in individuals wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Paliperidone Extended Release (paliperidone extended-release)

Snippet

Sponsor: Johnson & Johnson Taiwan Ltd | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2014-01-17